Prati
Jacqueline O'Leary, MD, MPH
Jacqueline O'Leary, MD, MPH
Dallas VA
Potvrđena adresa e-pošte na va.gov
Naslov
Citirano
Citirano
Godina
T cell–and B cell–independent adaptive immunity mediated by natural killer cells
JG O'Leary, M Goodarzi, DL Drayton, UH von Andrian
Nature immunology 7 (5), 507-516, 2006
10652006
Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis
MP Curry, JG O’Leary, N Bzowej, AJ Muir, KM Korenblat, JM Fenkel, ...
New England Journal of Medicine 373 (27), 2618-2628, 2015
9552015
Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease
M Charlton, GT Everson, SL Flamm, P Kumar, C Landis, RS Brown Jr, ...
Gastroenterology 149 (3), 649-659, 2015
9502015
Survival in infection‐related acute‐on‐chronic liver failure is defined by extrahepatic organ failures
JS Bajaj, JG O'Leary, KR Reddy, F Wong, SW Biggins, H Patton, ...
Hepatology 60 (1), 250-256, 2014
5312014
2016 comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection
AJ Demetris, C Bellamy, SG Hübscher, J O’leary, PS Randhawa, S Feng, ...
American Journal of Transplantation 16 (10), 2816-2835, 2016
5102016
Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end‐stage liver disease (NACSELD …
JS Bajaj, JG O'Leary, KR Reddy, F Wong, JC Olson, RM Subramanian, ...
Hepatology 56 (6), 2328-2335, 2012
4082012
Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end‐stage liver disease (NACSELD …
JS Bajaj, JG O'Leary, KR Reddy, F Wong, JC Olson, RM Subramanian, ...
Hepatology 56 (6), 2328-2335, 2012
4082012
Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study
MP Curry, X Forns, RT Chung, NA Terrault, R Brown Jr, JM Fenkel, ...
Gastroenterology 148 (1), 100-107. e1, 2015
3822015
AGA clinical practice update: coagulation in cirrhosis
JG O’Leary, CS Greenberg, HM Patton, SH Caldwell
Gastroenterology 157 (1), 34-43. e1, 2019
3642019
Management of the critically ill patient with cirrhosis: a multidisciplinary perspective
MK Nadim, F Durand, JA Kellum, J Levitsky, JG O’Leary, CJ Karvellas, ...
Journal of hepatology 64 (3), 717-735, 2016
3432016
Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1
TD Boyer, AJ Sanyal, F Wong, RT Frederick, JR Lake, JG O’Leary, ...
Gastroenterology 150 (7), 1579-1589. e2, 2016
3052016
New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection
F Wong, JG O'Leary, KR Reddy, H Patton, PS Kamath, MB Fallon, ...
Gastroenterology 145 (6), 1280-1288. e1, 2013
2742013
Indications for liver transplantation
JG O'Leary, R Lepe, GL Davis
Gastroenterology 134 (6), 1764-1776, 2008
2732008
De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients
H Kaneku, JG O’leary, N Banuelos, LW Jennings, BM Susskind, ...
American Journal of Transplantation 13 (6), 1541-1548, 2013
2672013
NACSELD acute‐on‐chronic liver failure (NACSELD‐ACLF) score predicts 30‐day survival in hospitalized patients with cirrhosis
JG O'leary, KR Reddy, G Garcia‐Tsao, SW Biggins, F Wong, MB Fallon, ...
Hepatology 67 (6), 2367-2374, 2018
2402018
Sensitization in transplantation: assessment of risk (STAR) 2017 working group meeting report
AR Tambur, P Campbell, FH Claas, S Feng, HM Gebel, AM Jackson, ...
American Journal of Transplantation 18 (7), 1604-1614, 2018
2342018
The 3‐month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis
JS Bajaj, KR Reddy, P Tandon, F Wong, PS Kamath, G Garcia‐Tsao, ...
Hepatology 64 (1), 200-208, 2016
2202016
Effectiveness of simeprevir plus sofosbuvir, with or without ribavirin, in real-world patients with HCV genotype 1 infection
MS Sulkowski, HE Vargas, AM Di Bisceglie, A Kuo, KR Reddy, JK Lim, ...
Gastroenterology 150 (2), 419-429, 2016
2182016
The role of donor-specific HLA alloantibodies in liver transplantation
JG O’leary, AJ Demetris, LS Friedman, HM Gebel, PF Halloran, AD Kirk, ...
American Journal of Transplantation 14 (4), 779-787, 2014
2112014
Frailty associated with waitlist mortality independent of ascites and hepatic encephalopathy in a multicenter study
JC Lai, RS Rahimi, EC Verna, MR Kappus, MA Dunn, ...
Gastroenterology 156 (6), 1675-1682, 2019
1902019
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20